MedPath

Rivastigmine Tartrate

These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000

Approved
Approval ID

0044f1d7-613c-4611-8481-13032c8cb390

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 21, 2022

Manufacturers
FDA

Alembic Pharmaceuticals Inc.

DUNS: 079288842

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rivastigmine Tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-066
Application NumberANDA091689
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rivastigmine Tartrate
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2022
FDA Product Classification

INGREDIENTS (9)

RIVASTIGMINE TARTRATEActive
Quantity: 6 mg in 1 1
Code: 9IY2357JPE
Classification: ACTIM
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT

Rivastigmine Tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-065
Application NumberANDA091689
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rivastigmine Tartrate
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2022
FDA Product Classification

INGREDIENTS (8)

RIVASTIGMINE TARTRATEActive
Quantity: 4.5 mg in 1 1
Code: 9IY2357JPE
Classification: ACTIM
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT

Rivastigmine Tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-063
Application NumberANDA091689
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rivastigmine Tartrate
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2022
FDA Product Classification

INGREDIENTS (8)

RIVASTIGMINE TARTRATEActive
Quantity: 1.5 mg in 1 1
Code: 9IY2357JPE
Classification: ACTIM
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

Rivastigmine Tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-064
Application NumberANDA091689
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rivastigmine Tartrate
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2022
FDA Product Classification

INGREDIENTS (9)

RIVASTIGMINE TARTRATEActive
Quantity: 3 mg in 1 1
Code: 9IY2357JPE
Classification: ACTIM
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rivastigmine Tartrate - FDA Drug Approval Details